Skip to content

Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry

Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01325467
Acronym
HyperQ
Enrollment
900
Registered
2011-03-29
Start date
2011-05-31
Completion date
2012-05-31
Last updated
2012-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

coronary artery disease, high frequency QRS analysis, ischemia, exercise testing, diagnosis of coronary artery disease

Brief summary

This will be a registry study that will enroll patients referred for an ECG treadmill test with nuclear myocardial perfusion imaging (MPI). The high frequency QRS (HFQRS) information will be recorded and analyzed automatically and simultaneous with the standard ECG signals by the HyperQ System. Results of subsequent tests performed on each patient will be collected and used to enhance the reliability of designating each patient as a CAD-negative (i.e., no significant coronary artery disease) or a CAD-positive (i.e., significant coronary artery disease).

Interventions

None listed

Sponsors

BSP Biological Signal Processing Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Referred for exercise MPI due to suspected coronary artery disease

Exclusion criteria

* Acute Coronary Syndrome (Unstable angina/NSTEMI/STEMI) * Pre-excitation syndrome * QRS duration \> 120 ms * Atrial Fibrillation or significant ventricular arrhythmia * Treatment with Digoxin * Pacemaker with 100% pacemaker dependence

Design outcomes

Primary

MeasureTime frameDescription
CAD statusone month follow upThe main goal of this registry will be to compare sensitivity, specificity, positive and negative predictive values of the HyperQ HFQRS analysis for detecting the presence of coronary artery disease to that of standard ECG analysis.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026